Navigation Links
Pharma Wholesale and Distribution Market: World Outlook 2012-2022
Date:8/2/2012

NEW YORK, Aug. 2, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Pharma Wholesale and Distribution Market: World Outlook 2012-2022

http://www.reportlinker.com/p0943306/Pharma-Wholesale-and-Distribution-Market-World-Outlook-2012-2022.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pharmaceutical

Report Details Your guide to trends and revenue potential in pharma wholesaling and distribution

Where is the pharmaceutical wholesale and distribution (W&D) industry heading? Visiongain's report shows you potential revenues and trends to 2022, discussing data, opportunities and prospects.

This new study investigates the W&D industry and its market environment. It lets you discover projected revenues at overall world market, main submarket, company and national level to 2022.

You see forecasts of world-level submarkets to 2022, finding potential revenue: • Original-branded drugs• Generic drugs.

How will 11 leading countries perform to 2022? You find W&D revenue forecasts, as well as discussions of what will drive and restrain those national markets:

• US

• Japan

• Germany

• France

• UK

• Spain

• Italy

• China

• Brazil

• Russia

• India.

You also find a revenue forecast to 2022 for the overall European W&D market. Our study lets you assess the worldwide industry and market, seeing trends and outlooks. You find discussions of pharma supply issues such as these:

• Prospects for the pharma distribution chain from 2012 onwards

• Roles of pharmaceutical wholesalers

• Fu
'/>"/>

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. PAREXEL Strengthens Outcomes Research Capabilities To Help Biopharma Meet Commercialization Goals
2. Onyx Pharmaceuticals Reports Second Quarter 2012 Financial Results
3. Save Up To 25% on International Biotech and Healthcare, and Pharmaceutical Conferences by Registering Through GII
4. Genelex Receives First Patent on Business Methods for Pharmacogenetics
5. Qforma Chief Technologist Honored as One of PharmaVOICE Magazines "100 Most Inspiring People in the Life Sciences"
6. MAP Pharmaceuticals, Inc. Prices Public Offering of Common Stock
7. Avanir Pharmaceuticals Announces Date Of Fiscal 2012 Third Quarter Financial Results And Conference Call
8. AcelRx Pharmaceuticals Receives Two Additional U.S. Patents for Small-Volume Oral Transmucosal Dosage Forms
9. Actinium Pharmaceuticals Announces The Addition of The Fred Hutchinson Cancer Research Center To Actiniums Multicenter Clinical Trial For Patients With Acute Myeloid Leukemia
10. CPhI China 2012 Breaks Attendance Records in Growing Pharma Market
11. Synergy Pharmaceuticals to Present Scientific Posters at the Upcoming Gastroenterology Society Meetings in the U.S. and Europe
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... July 30, 2015  Amgen (NASDAQ: AMGN ... quarter of 2015. Key results include: , ... quarter of 2014 to $5,370 million, with 6 ... ® (etanercept), Prolia ® (denosumab), Sensipar ... XGEVA ® (denosumab). Unfavorable changes in foreign ...
(Date:7/30/2015)... China , July 30, 2015 Tianyin ... a pharmaceutical company that specializes in the patented biopharmaceutical, ... pharmaceutical ingredients (API), provided updates regarding the notice it ... LLC (the "Exchange") indicating that the Company was below ... forth in Sections 134 and 1101 of the NYSE ...
(Date:7/30/2015)...  Growth of the U.S. nonprescription market is primarily ... users to the OTC market. Due to an increasingly ... switch activity over the next five years with several ... brands entering the market into existing categories. ... (even those with low to moderate likelihood), the market ...
Breaking Medicine Technology:Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 2Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 3Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 4Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 5Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 6Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 7Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 8Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 9Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 10Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 11Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 12Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 13Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 14Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 15Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 16Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 17Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 18Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 19Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 20Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 21Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 22Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 23TPI Provides Update Regarding Non-Compliance with NYSE MKT Continued Listing Requirements 2Rx-to-OTC Switches -- Game Changers for the U.S. OTC Drugs Market through 2019, Sees Kline 2Rx-to-OTC Switches -- Game Changers for the U.S. OTC Drugs Market through 2019, Sees Kline 3
... Robert Mazzacavallo has joined Veridiam as the company,s Chief ... of high-precision, fabricated assemblies and metal components, primarily serving ... aerospace and general industrial markets. , Before joining Veridiam, ... Camas, WA. At C-Tech, Bob worked closely with ...
... 3 Corgenix Medical Corporation (OTC Bulletin Board: CONX), ... will host a conference call on Thursday, November 12, ... financial and operating performance for the first quarter ended ... product development and marketing activities. , Corgenix invites all ...
Cached Medicine Technology:Veridiam Names Robert Mazzacavallo New CFO 2
(Date:7/31/2015)... ... July 31, 2015 , ... Well-known for its unique ... wedding cakes with custom designs, making life just a little bit sweeter ... wedding cakes for each customer who orders one. , The bakery provides a full ...
(Date:7/31/2015)... ... July 31, 2015 , ... The 2015 New York ... family members, medical professionals, and researchers, covering a variety of topics related to ... collaborative effort between the Mesothelioma Applied Research Foundation and Memorial Sloan Kettering Cancer ...
(Date:7/31/2015)... ... 2015 , ... Girl Scouts of Historic Georgia and Peach State Health Plan ... "Be a Friend First" program. Representatives from Peach State Health Plan presented a $10,000 ... Plan and our parent company, Centene Corporation, are dedicated to raising anti-bullying awareness. We ...
(Date:7/31/2015)... , ... July 31, 2015 , ... BioViva USA, Inc. ... way we treat aging diseases. , BioViva announces it has begun a fundraiser ... with Alzheimer’s Disease (AD) and find a cure. MaxLife will grant 100% of the ...
(Date:7/31/2015)... Calgary, AB (PRWEB) , ... July 31, 2015 , ... ... changes. "When patients don't experience angina until a heart rate of 150 beats versus ... Fit Clinic in Calgary. "We are able to give life back to patients with ...
Breaking Medicine News(10 mins):Health News:Pastry Palace of Las Vegas Announces It Is Now Offering Custom Wedding Cakes in Las Vegas 2Health News:New York Area Mesothelioma Specialists to Present at Conference 2Health News:New York Area Mesothelioma Specialists to Present at Conference 3Health News:Peach State Health Plan Presents $10,000 Check for “Be a Friend First” Anti-Bullying Program to Local Girl Scouts 2Health News:BioViva USA, Inc.’s Alzheimer’s Disease Gene Therapy Human Trial 2Health News:BioViva USA, Inc.’s Alzheimer’s Disease Gene Therapy Human Trial 3Health News:Heart Fit Clinic Helps Patient Increase Fitness Level with External Counterpulsation 2
... for majority of patients, survey found , WEDNESDAY, Aug. ... associated with neck problems, according to the results of ... aged 25 to 78, who had two types of ... (spine fusion). , Before the surgery, 86.4 percent of ...
... , NEW YORK, Aug. 12 ... of Ogilvy Healthworld North America, have been appointed Joint Worldwide CEOs ... Young. , , In making the announcement, Mr. ... they are also very complementary individuals. Their joint mandate is ...
... ... business culture and long history of technology innovation to enhance research, development and innovation ... Scottsdale, AZ ... management and security, today announced the expansion of its global operations with the opening ...
... Aug. 12 With obesity now the greatest threat to the health ... than ever. According to a new study in the August 2009 ... American Dietetic Association , portion and calorie-controlled meal replacements used in ... , , The st u ...
... SWARTZ CREEK, Mich., Aug. 12 Diplomat Specialty Pharmacy announced today they ... Inc.,s annual ranking of the fastest-growing private companies in America. ... is an amazing achievement, the additional details are even more resounding," stated Phil ... , , , Of the 43 ...
... , , DANA POINT, Calif., Aug. ... have selected Artefill, the first and only FDA-approved microsphere-enhanced collagen filler ... looking for a longer lasting dermal filler. Drs. Kofford have been ... success and effectiveness for the correction of wrinkles. , ...
Cached Medicine News:Health News:Surgery for Neck Pain May Also Relieve Headaches 2Health News:Joint Worldwide CEO's of Ogilvy Healthworld Named 2Health News:Lumension Expands Global Footprint and Strengthens Capabilities with the Opening of a New Development Office in Ireland 2Health News:Lumension Expands Global Footprint and Strengthens Capabilities with the Opening of a New Development Office in Ireland 3Health News:New Published Diet Study Reveals Meal Replacements as Top Strategy for Weight Loss 2Health News:Diplomat Specialty Pharmacy Honored By Inc. Magazine As One Of The Nation's Fastest-Growing Companies 2Health News:Riviera Laser Studios Selects Artefill to Meet Growing Patient Demand for a Longer Lasting Dermal Filler 2Health News:Riviera Laser Studios Selects Artefill to Meet Growing Patient Demand for a Longer Lasting Dermal Filler 3
... 3200 sets a benchmark of innovative, ... for WBC, RBC, PLT and Reticulocyte ... needs of today's laboratory. The instrument ... analysis, automated sample handling, comprehensive data ...
... Data Management System provides comprehensive program management ... and the Precision PCx. The QC Manager ... collect, analyze, and report quality control data ... essential laboratory tool for managing data and ...
... The CELL-DYN SMS consistently produces high-quality ... ensuring consistent blood films every time, eliminating ... with significantly high or low hematocrit values. ... autoloader mixes, identifies the sample, and aspirates ...
... The QuickVue In-Line Strep A Test allows for ... directly from patient throat swab specimens. , ,QuickVue ... and is the first strep A test waived ... rapid procedure allow testing to take place at ...
Medicine Products: